INCIDENTAL NEUROBLASTOMA
Authors:
Jerzy Armata a;
Agnieszka D
u
niewska a;
Katarzyna Garus a;
Walentyna Balwierz;
Witold Mie
y
ski b;
Ma
gorzata Hnatko-Ko
acz a
u
niewska a;
Katarzyna Garus a;
Walentyna Balwierz;
Witold Mie
y
ski b;
Ma
gorzata Hnatko-Ko
acz a
| Affiliations: | a Department of Pediatric Oncology and Hematology, Polish-American Children's Hospital, Collegium Medicum, Jagiellonian University, Krak w, Poland. |
b Department of Pathology, Polish-American Children's Hospital, Collegium Medicum, Jagiellonian University, Krak w, Poland. |
DOI:
10.1080/08880010050211385
Publication Frequency:
8 issues per year
Subjects:
Oncology: Hematologic Oncology;
Hematology: Hematologic Oncology;
Pediatrics & Child Health;
Formats available:
PDF
(English)
View Article:
View Article (PDF)
Abstract
The diagnosis of neuroblastoma in its early stage, especially in asymptomatic children, with the so-called incidentally diagnosed disease, may be associated with a good prognosis. The aim of this study is an attempt at analyzing this problem. Between 1 January 1993 and 30 April 1998, 40 children with newly diagnosed neuroblastoma started therapy at the authors' department. The disease was diagnosed incidentally in 5 (12.5%) patients. In no incidentally diagnosed child was stage IV disease detected, while in the remaining patients its incidence was 71%. All the children (median age 2 months) with incidental diagnosis have remained alive (median 39 months) in continuos remission without treatment. Among 35 children (median age 2 years and 7 months) with overt neuroblastoma, 18 died (median survival time 14.5 months). Seventeen patients have remained alive (median 45 months). The results show that children with incidentally diagnosed neuroblastoma are characterized by a more favorable prognosis than children with clinical disease.
|
| Keywords: Incidental Diagnosis; Neuroblastoma; Screening Methods; Treatment Strategy |


Download Citation
w, Poland.
CiteULike
Del.icio.us
BibSonomy
Connotea